How might patients access the COVID-19 antiviral pill?

Published 2022-01-18
Infectious diseases specialists Dr. Susy Hota and Dr. Isaac Bogoch talk about how people might be able to access the new COVID-19 antiviral pill, Paxlovid, and how it could impact the health-care system.

00:00 How will people get access to Paxlovid?
01:16 Where will Paxlovid be available?
02:02 Who can't use Paxlovid?
03:14 Not a replacement for vaccination

#AntiViralPill #Paxlovid #Pfizer

Watch The National live on YouTube Sunday-Friday at 9 p.m. ET

Subscribe to The National:
youtube.com/user/CBCTheNational?sub_confirmation=1

Connect with The National online:
Facebook | www.facebook.com/thenational
Twitter | twitter.com/CBCTheNational
Instagram | www.instagram.com/cbcthenational

More from CBC News | www.cbc.ca/news

The National is CBC's flagship nightly news program, featuring the day's top stories with in-depth and original journalism, with hosts Adrienne Arsenault and Andrew Chang in Toronto, Ian Hanomansing in Vancouver and the CBC's chief political correspondent, Rosemary Barton in Ottawa.